ADL
FLXN

Asset Dedication LLC’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Asset Dedication LLC’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10
Closed – – 782
2018
Q1 		$0 Buy
+10
New +$244 ﹤0.01% 567

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Asset Dedication LLC's FLXN Position: Q2 2018 in Review

Asset Dedication LLC sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2018, closing a stake of 10 shares.

Asset Dedication LLC first reported a position in FLXN in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 130 funds tracked by Wall St. Rank hold FLXN as of Q2 2018.

  • Asset Dedication LLC reported no remaining Flexion Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Asset Dedication LLC sold 10 Flexion Therapeutics, Inc. shares in Q2 2018.
  • Asset Dedication LLC first reported a position in Flexion Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • Asset Dedication LLC's Flexion Therapeutics, Inc. position peaked at $0 in Q1 2018.
  • 130 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2018.

Based on Asset Dedication LLC's 13F filing for Q2 2018, filed 13 Aug 2018.